The cost-effectiveness of orphan drugs.
作者信息
Weinstein M C
出版信息
Am J Public Health. 1991 Apr;81(4):414-5. doi: 10.2105/ajph.81.4.414.
Abstract
摘要
相似文献
1
The cost-effectiveness of orphan drugs.孤儿药的成本效益。
Am J Public Health. 1991 Apr;81(4):414-5. doi: 10.2105/ajph.81.4.414.
2
Should health-care systems pay for replacement therapy in patients with alpha(1)-antitrypsin deficiency? A critical review and cost-effectiveness analysis.医疗保健系统是否应为α1-抗胰蛋白酶缺乏症患者支付替代疗法的费用？一项批判性综述与成本效益分析。
Chest. 2000 Mar;117(3):875-80. doi: 10.1378/chest.117.3.875.
3
Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease.α-1抗胰蛋白酶替代疗法治疗先天性慢性阻塞性肺疾病的成本效益
Am J Public Health. 1991 Apr;81(4):427-33. doi: 10.2105/ajph.81.4.427.
4
Clinical trials to treat the underlying cause of emphysema.治疗肺气肿根本病因的临床试验。
Monaldi Arch Chest Dis. 1994 Apr;49(2):95-7.
5
6
Lung transplantation for alpha 1-antitrypsin deficiency emphysema.α1抗胰蛋白酶缺乏性肺气肿的肺移植
Chest. 1996 Dec;110(6 Suppl):284S-294S. doi: 10.1378/chest.110.6_supplement.284s.
7
A role for intermediate, heterozygous alpha 1-antitrypsin deficiency in obstructive lung disease.
Chest. 1990 Sep;98(3):522-3. doi: 10.1378/chest.98.3.522.
8
[Genetics of alpha 1-antitrypsin and chronic obstructive lung diseases].
Ter Arkh. 1977;49(10):132-8.
9
Assessing the economic challenges posed by orphan drugs.评估罕见病药物带来的经济挑战。
Int J Technol Assess Health Care. 2007 Winter;23(1):36-42. doi: 10.1017/S0266462307051550.
10
Orphan drugs and the NHS: fairness in health care entails more than cost effectiveness.孤儿药与英国国家医疗服务体系：医疗保健中的公平性所涉及的远不止成本效益。
BMJ. 2005 Nov 12;331(7525):1144-5. doi: 10.1136/bmj.331.7525.1144-c.
引用本文的文献
1
Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities.制造商产品说明书中儿科药物安全性的记录：对《加拿大药品和特殊产品汇编》的横断面评估
Paediatr Drugs. 2008;10(3):193-7. doi: 10.2165/00148581-200810030-00007.
本文引用的文献
1
Economic evaluation and the rational diffusion and use of health technology.卫生技术的经济评估与合理推广及应用
Health Policy. 1987 Jun;7(3):309-24. doi: 10.1016/0168-8510(87)90072-8.
2
Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.直击胆固醇。治疗高胆固醇血症的经济有效替代方案。
JAMA. 1988 Apr 15;259(15):2249-54. doi: 10.1001/jama.259.15.2249.
3
Cost-effectiveness of interventions to prevent or treat coronary heart disease.预防或治疗冠心病干预措施的成本效益
Annu Rev Public Health. 1985;6:41-63. doi: 10.1146/annurev.pu.06.050185.000353.
4
Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease.α-1抗胰蛋白酶替代疗法治疗先天性慢性阻塞性肺疾病的成本效益
Am J Public Health. 1991 Apr;81(4):427-33. doi: 10.2105/ajph.81.4.427.
Zotero 插件